PWAR5 and glioma: This exploration, conducted in glioma-cultured cells, also revealed that restoring PAR5 significantly reduced EGFR, VEGF-A, and cyclin A levels while decreasing AKT phosphorylation, highlighting this lncRNA tumor suppressor’s ability to direct methylation suppression on these oncogenes.